Clinical Trials Directory

Trials / Sponsors / Immunocore Ltd

Immunocore Ltd

Industry · 15 registered clinical trials — 5 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingStudy of IMC-S118AI in Type 1 Diabetes
Type 1 Diabetes, Type 1 Diabetes (T1D), Diabetes Type 1
Phase 12026-04-01
RecruitingStudy of IMC-P115C in Advanced PRAME-Positive Cancers
PRAME Positive, Cancer, HLA-A*02:01-positive
Phase 12024-11-07
RecruitingIMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Advanced Melanoma
Phase 32024-06-05
RecruitingPhase 1/2 Study of IMC-R117C in Selected Advanced Cancers
Cancer, HLA-A*02:01-positive
Phase 1 / Phase 22024-01-10
RecruitingTebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Advanced Melanoma
Phase 32022-12-19
WithdrawnStudy of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection
Hepatitis B, Chronic
Phase 12020-08-12
Active Not RecruitingSafety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
Select Advanced Solid Tumors
Phase 1 / Phase 22020-02-25
WithdrawnSafety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab
Select Advanced Solid Tumors
Phase 1 / Phase 22019-05-17
TerminatedSafety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers
Select Advanced Solid Tumors
Phase 1 / Phase 22018-06-15
CompletedSafety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Uveal Melanoma
Phase 22017-10-16
TerminatedIMCgp100-401 Rollover Study
Malignant Melanoma
Phase 22017-01-11
CompletedA Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
Uveal Melanoma
Phase 1 / Phase 22016-02-29
WithdrawnPhase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Mela
Malignant Melanoma
Phase 1 / Phase 22015-11-01
CompletedStudy to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant Melanoma
Malignant Melanoma
Phase 12010-09-28
AvailableA Cohort IND Expanded Access Program for Supporting Patient Access to Tebentafusp
Uveal Melanoma
——